Safety Profile Data The estimated toxic dose for GHK-Cu sits approximately 300-fold higher than therapeutic research doses
Biomarker assessmentincluding fasting glucose, HbA1c trajectory, lipid panels, and inflammation markershelps providers evaluate whether 7.5mg is producing intended metabolic shifts
This collaboration is part of potential $7 billion partnership struck between Flagship and Pfizer in 2023
Long-Term Costs Weight loss phases are generally planned out over a period of several months, but the financial strain can last longer
Whether youre just starting your journey or have struggled for years, our weight loss clinic offers personalized, medically supervised solutions to help you achieve real, lasting results
Spacing injections more than 4 days apart creates a gap in coverage